BioMarin Pharmaceuticals
BMRN
BMRN
388 hedge funds and large institutions have $16.9B invested in BioMarin Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 150 increasing their positions, 141 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
388
Holders Change
-5
Holders Change %
-1.27%
% of All Funds
10.19%
Holding in Top 10
9
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-35.71%
% of All Funds
0.24%
New
50
Increased
150
Reduced
141
Closed
52
Calls
$249M
Puts
$199M
Net Calls
+$49.4M
Net Calls Change
+$65.8M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$182M |
| 2 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$166M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$104M |
| 4 |
Temasek Holdings
Singapore
|
+$93.1M |
| 5 |
Goldman Sachs
New York
|
+$70.3M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$207M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$99.7M |
| 3 |
AC
Amici Capital
New York
|
-$48.2M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$38.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$37M |
